Surgical Clarity - In Real Time
- Redefining Surgical Margin Assessment
3Sonic is a clinical spin-out from the SURGiC research group at Rigshospitalet’s Department of Otorhinolaryngology. We are developing a 3D ultrasound imaging
platform designed to assist surgeons in real-time during cancer operations.
Our goal is to improve patient outcomes by making tumor margin assessment faster, more precise, and available directly in the operating room.
Innovative Cancer Tumor Imaging Platform: designed for real-time, instant use in the operating room
Substantial Market Opportunity: targeted market potential of $60 billion, addressing significant
demand in global medical imaging sector.
Proven Clinical Efficacy: Clinical proof of concept completed with oral cancer patients.
Enhanced Patient Outcomes and Cost Efficiency: boosts surgical precision and reduces treatment-related costs
Advanced Prototype Development: Fully functional prototype of imaging platform constructed.
Attractive to Investors: Compelling opportunity for venture capital funding to fuel further development and market penetration.
​​Developed by clinicians and researchers from the SURGiC group at Rigshospitalet, 3Sonic is an innovative 3D ultrasound imaging platform created to support surgeons during cancer operations. By enabling real-time scanning of resected tumors, the system helps assess whether the surgical margin is sufficient—directly in the operating room.
​
Our clinically tested prototype has been used on oral cancer patients and demonstrated strong potential to streamline surgical workflows. The platform combines custom-built hardware with specialized software, designed for portability, speed, and intuitive use without the need for external sensors.
​
This approach not only enhances surgical precision and minimizes unnecessary removal of healthy tissue, but also reduces the risk of repeat procedures—improving outcomes for patients and reducing costs for hospitals. With a targeted market potential exceeding $60 billion, 3Sonic offers a compelling opportunity for investors seeking to support meaningful innovation in cancer care.
Competing Features
Portable
Fast (5 minutes)
Sensorless
Cost-effective
The 3Sonic platform is built with the surgical environment in mind—compact, mobile, and ready to use in a variety of clinical settings. Its streamlined design removes the need for external tracking systems, making it easier to integrate into existing workflows without additional setup or equipment.
​
High-resolution 3D scans are generated in under ten minutes, giving surgical teams immediate visual feedback during critical decision-making. This rapid insight can help avoid delays, reduce patient risk, and lessen the reliance on long post-operative pathology timelines. By minimizing the need for follow-up procedures and preserving healthy tissue, 3Sonic contributes to more efficient care and long-term savings for healthcare providers.